Cargando…

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct

SIMPLE SUMMARY: Chronic lymphocytic leukemia (CLL) is characterized by a highly variable clinical course. Thus, predicting the outcome of patients with this disease is a topic of special interest. The rapidly changing treatment landscape of CLL has questioned the value of classical biomarkers and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Gascón-y-Marín, Isabel, Muñoz-Novas, Carolina, Rodríguez-Vicente, Ana-Eugenia, Quijada-Álamo, Miguel, Hernández-Sánchez, María, Pérez-Carretero, Claudia, Ramos-Ascanio, Victoria, Hernández-Rivas, José-Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068228/ https://www.ncbi.nlm.nih.gov/pubmed/33917885 http://dx.doi.org/10.3390/cancers13081782

Ejemplares similares

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
por: Pérez-Carretero, Claudia, et al.
Publicado: (2021)

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2023)

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
por: Muñoz-Novas, Carolina, et al.
Publicado: (2018)

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
por: Quijada-Álamo, Miguel, et al.
Publicado: (2021)

Will Specialists Become Extinct?
Publicado: (1893)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
por: Quijada‐Álamo, Miguel, et al.
Publicado: (2021)

PB2293: REAL WORLD STUDY OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE ELDERLY: FOURTEEN YEARS OF ONE CENTER’S EXPERIENCE
por: De Ascanio, Victoria Ramos, et al.
Publicado: (2023)

P1136: INTERIM IMAGING DOES NOT PREDICT CLINICAL EVOLUTION IN FOLLICULAR LYMPHOMA IN A REAL-LIFE CLINICAL SETTING
por: Ramos De Ascanio, V., et al.
Publicado: (2022)

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively
por: Moreno, Carol, et al.
Publicado: (2021)

Why Would Plant Species Become Extinct Locally If Growing Conditions Improve?
por: Kramer, Koen, et al.
Publicado: (2012)

P1608: EXPERIENCE AND COMPLICATIONS WITH THE USE OF PICCS IN HEMATOLOGIC PATIENTS
por: Sanchez-Paz, L., et al.
Publicado: (2022)

When Did Carcharocles megalodon Become Extinct? A New Analysis of the Fossil Record
por: Pimiento, Catalina, et al.
Publicado: (2014)

Future of the Higher Education Conglomerates: Evolve (in a Hurry) or Go Extinct
por: Kuddus, Ruhul H.
Publicado: (2013)

Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons
por: Rodríguez-Vicente, Ana E., et al.
Publicado: (2017)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

Correction: When Did Carcharocles megalodon Become Extinct? A New Analysis of the Fossil Record
Publicado: (2015)

Why did the dinosaurs become extinct? Could cholecalciferol (vitamin D(3)) deficiency be the answer?
por: Fraser, D. R.
Publicado: (2019)

Expansion, Exploitation and Extinction: Niche Construction in Ephemeral Landscapes
por: Wetherington, Miles T., et al.
Publicado: (2020)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Dopamine in Fear Extinction
por: Salinas-Hernández, Ximena I., et al.
Publicado: (2021)

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
por: Quijada-Álamo, Miguel, et al.
Publicado: (2017)

Replaying Evolution to Test the Cause of Extinction of One Ecotype in an Experimentally Evolved Population
por: Turner, Caroline B., et al.
Publicado: (2015)

Ecological conditions determine extinction risk in co-evolving bacteria-phage populations
por: Wright, Rosanna C. T., et al.
Publicado: (2016)

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
por: Ahmadmehrabi, Khashayar, et al.
Publicado: (2021)

Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
por: Rodríguez, Ana Eugenia, et al.
Publicado: (2012)

BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field
por: Chap, Christna
Publicado: (2013)

Evolving landscape in the management of transthyretin amyloidosis
por: Hawkins, Philip N., et al.
Publicado: (2015)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
por: Shreve, Jacob, et al.
Publicado: (2020)

Evolving generalists in switching rugged landscapes
por: Wang, Shenshen, et al.
Publicado: (2019)

The Evolving Landscape of Cardiovascular Disease Prevention
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2021)

The Evolving Landscape of Fecal Microbial Transplantation
por: Shao, Tihong, et al.
Publicado: (2023)

The evolving landscape of thoracic surgical oncology
por: Kim, Anthony W., et al.
Publicado: (2023)

Experience and Perspectives in the US on the Evolving Treatment Landscape in Spinal Muscular Atrophy
por: Ramos-Platt, Leigh, et al.
Publicado: (2022)

Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?
por: Paget, John, et al.
Publicado: (2022)

Mutation Status and Immunoglobulin Gene Rearrangements in Patients from Northwest and Central Region of Spain with Chronic Lymphocytic Leukemia
por: González-Gascón y Marín, I., et al.
Publicado: (2014)

Toxin production spontaneously becomes regulated by local cell density in evolving bacterial populations
por: Doekes, Hilje M., et al.
Publicado: (2019)

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
por: García-Tuñón, Ignacio, et al.
Publicado: (2017)

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence
por: Feagan, Brian G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5dtkqlh06qs9t5rapf0248b334